News for Jubilant Ingrevia Limited (JUBLINGREA.NS)

Jubilant Ingrevia partners with O2 Power for renewable energy, meeting 50% of SEZ Bharuch facility's needs.

India's benchmark indices ended lower on Wednesday, pressured by financial and consumer stock sell-offs amid cautious market sentiment ahead of corporate earnings and concerns over limited U.S. Federal Reserve interest rate cuts.

Indian markets declined on Thursday, dragged by global market weakness after the Fed's hawkish stance. Selling pressure was seen across sectors, especially in banking and real estate. FII outflows and a strong dollar further weighed on the market. Defensive sectors like pharma outperformed.

Oct 22, 2024 / 11:30AM GMTOperator Ladies and gentlemen, good day and welcome to Jubilant Ingrevia's Q2 FY25 earnings conference call. As a reminder, all partic

Jubilant Ingrevia's Gujarat facility joins the World Economic Forum's Global Lighthouse Network, emphasizing its role in AI-driven manufacturing transformation. By employing 4IR technologies and reskilling over 2,000 employees, the site improved process efficiency and aims to further reduce emissions and enhance digital interventions across all plants.

Indian indices fell sharply on Thursday, dragged by Middle East tensions. Nifty closed at 25,250, down 2.12%. Analyst Rupak De sees a bearish trend reversal, with support at 25,070. Tejas Shah sees potential for a minor pullback rally, with support at 25,200-25,050 and resistance at 25,475-25,700.

The Nifty Bank index was trading 1.02 per cent down at 52382.4.

Stocks in focus: Buzzing stocks: Hindustan Zinc, Dr Reddy’s Lab, Zydus Life, RPower, Suzlon, Adani Enterprises, Jubilant Ingrevia, SpiceJet, Rathi Steel, Mankind Pharma, Shree Cement, JSW Cement, ITC, Aurobindo Pharma, Ashoka Buildcon

Stock Market today | Share Market Updates - Find here all the updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for October 3, 2024

The Nifty index ended its 14-day winning streak, falling 0.32% to 25,198 due to global market concerns and U.S. economic uncertainty. Analysts suggest a "buy on dips" strategy while maintaining support at 25,000-25,100, with potential resistance at 25,300-25,500.

The NSE Nifty index closed 81.15 points down at 25198.7

Investors are now focusing on the minutes of the latest Fed policy meeting and Fed Chair Powell's upcoming address later this week, seeking clues on the U.S. rate cut trajectory.

Benchmarks pared initial losses after starting lower on Monday following new allegations by US-based short-seller Hindenburg Research

Domestic blue-chip equity indices Sensex and Nifty closed over 1% higher on Friday, led by IT stocks, as a larger-than-expected drop in U.S. unemployment claims eased recession fears in the world's largest economy.

"On the daily charts, we can observe that Nifty has managed to close above the 40-day average (24138). India Vix has cooled off and there has been a significant improvement in market breadth. All these parameters are suggesting that the Nifty is likely to witness continuation of the pullback. On the upside, 24520 – 24550 is the immediate hurdle while 24000 is the immediate support zone from a short term perspective," said Jatin Gedia of Sharekhan.

According to Nagaraj Shetti of HDFC Securities the short-term trend of Nifty is down, but the near-term uptrend status of the market is intact. There is a possibility of some more weakness in the coming sessions down to 24,600-24,500 levels before showing any upside bounce from the lows. Immediate resistance is at 24,900 levels.

Nifty soared to a new record high on Tuesday, forming a bullish pattern on the charts. After breaking through the 24,400 resistance level, the next target for the index could be 24,960. The momentum indicator showed bullish trade on the counters of BASF India, Kaynes Technology, Hindustan Aeronautics, Britannia Industries, and Colgate-Palmolive (India).

Stock market holiday: On Wednesday, Nifty50 touched a lifetime peak of 22,776 during intraday trade. It eventually closed 111 points or 0.49 per cent higher at 22,754-level. The 30-share BSE pack settled 354 points or 0.47 per cent higher at 75,038.

The Nifty Pharma index closed 0.34 per cent down at 19117.0.